PMC9471138_01
Brain MRI scan of the patient: axial (A) and coronal (B) images show no microscopic signs of metastases in cavernous sinus. Gadolinium-enhanced axial (C) and coronal (D) images show no obvious altered dural enhancement along lateral walls of both cavernous sinuses.
fsurg-09-893651-g001.jpg
PMC9471138_01_fsurg-09-893651-g001.jpg
F1
Brain magnetic resonance imaging (MRI) scan found no microscopic signs of metastases in cavernous sinus (Figures 1A,B) and contrast-enhanced revealed no enhancement of the corresponding cranial nerve (Figures 1C,D).
PET-CT scan (A) compared with the images 10 months ago (B), CT scan shows isointense soft tissue filling the suprasellar region, while FDG accumulation in bilateral cavernous sinuses.
fsurg-09-893651-g002.jpg
PMC9471138_01_fsurg-09-893651-g002.jpg
F2
Compared with the images 10 months ago, there was FDG accumulation in bilateral cavernous sinuses and the CT scan showed isometric soft tissue filling the suprasellar region (Figure 2).
18F-FDG-PET scan shows hypermetabolic foci located from the origin of superior vena cava, expanding to the right cephalbrachial vein, with entrance to the right common jugular vein, right internal jugular vein, and vertebral vein.
fsurg-09-893651-g003.jpg
PMC9471138_01_fsurg-09-893651-g003.jpg
F3
The hypermetabolic foci were found located from the origin of the superior vena cava, expanding to the right cephalbrachial vein, the right clavicular vein with entrance to the right common jugular vein, the right internal jugular and vertebral veins, and progressed cranially to the suprasellar region (Figure 3).
The timeline shows the course of the disease. Due to the palliative regimen, the patient deteriorated rapidly and passed away 3 months after admission.
fsurg-09-893651-g004.jpg
PMC9471138_01_fsurg-09-893651-g004.jpg
F4